Mindfulness meditation for patients after heart rehabilitation
Impact of Mindfulness-Based Stress Reduction Meditation Practice on Medium- and Long-term Follow-up of Cardiac Patients After Cardiac Rehabilitation.
NA · Elsan · NCT06438159
This study tests if mindfulness meditation can help heart patients feel less anxious and depressed while they go through cardiac rehabilitation.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 74 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Elsan (other) |
| Locations | 1 site (Aressy) |
| Trial ID | NCT06438159 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of Mindfulness-Based Stress Reduction (MBSR) meditation on patients undergoing cardiac rehabilitation. It aims to address the anxiety and depression that many cardiac patients experience, which can hinder their recovery and adherence to treatment. Participants will engage in an 8-week MBSR program alongside conventional cardiac rehabilitation to evaluate improvements in their mental health and overall rehabilitation outcomes.
Who should consider this trial
Good fit: Ideal candidates are cardiac patients eligible for rehabilitation who exhibit moderate anxiety or depression.
Not a fit: Patients with severe psychiatric disorders or those unable to participate in the MBSR program may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the mental well-being and recovery of cardiac patients, leading to better rehabilitation outcomes.
How similar studies have performed: Previous studies have shown promising results for mindfulness interventions in improving mental health outcomes in various patient populations, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Cardiac patients eligible for cardiac rehabilitation, 2. Patient with a Hospital Anxiety and Depression Scale (HADS) score for the anxiety dimension (HADS-A) \>7 or a score for the depression dimension (HADS-D) \> 7 3. Age ≥ 18 years 4. Affiliated with a social security scheme or beneficiary of such a scheme 5. Patient signed free and informed consent form Exclusion Criteria: 1. Patients already treated for severe psychiatric disorders (major depression, psychosis, schizophrenia) 2. Inability to follow the 8-week MBSR program 3. Protected patient: minor, adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision 4. Medical conditions which may interfere with the conduct of the study and the investigator's judgment, and which may render the patient unfit to participate in the study. 5. Pregnant or breast-feeding patient 6. Refusal to participate in the study or inability to comply with the study protocol for any reason whatsoever
Where this trial is running
Aressy
- Clinique d'Aressy — Aressy, France (RECRUITING)
Study contacts
- Study coordinator: Bernard Truong, MD
- Email: recherche.na@elsan.care
- Phone: 0556003048
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiac Disease, cardiac rehabilitation, MBSR